The pathologist's slide reveals more than meets the eye: Loss of heterozygosity and cancer biology

Veterinary Pathology

Volumn 48, Issue 1, 2011, Pages 236-244

  Couto, S S ^a  

^a GENENTECH INC   (United States)

Author keywords

comparative genomic hybridization; LOH; loss of heterozygosity; microarrays; microsatellites; mitotic recombination; tumor suppressor gene loss

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; GENETICS; HETEROZYGOSITY LOSS; METABOLISM; NEOPLASM; VETERINARY MEDICINE;

ANIMALS; LOSS OF HETEROZYGOSITY; NEOPLASMS; PATHOLOGY, VETERINARY;

EID: 79951904015     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810379432     Document Type: Article

References (57)

1. Abruzzo MA, Hassold TJ: Etiology of nondisjunction in humans. Environ Mol Mutagen 25(suppl 26):38-47, 1995.
2. Aghi MK, Batchelor TT, Louis DN, Barker FG 2nd, Curry WT Jr: Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q. J Neurooncol 93:115-120, 2009.
3. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P., Ledbetter DH, Barker DF, Nakamura Y., White R., Vogelstein B.: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221, 1989.
4. Banach-Petrosky W., Ouyang X., Gao H., Nader K., Ji Y., Suh N., DiPaola RS, Abate-Shen C.: Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice. Clin Cancer Res 12:5895-5901, 2006.
5. Bayani J., Squire J.: Multi-color FISH techniques. Curr Protoc Cell Biol 22:Unit22.25, 2004.
6. Bayani J., Squire JA: Comparative genomic hybridization. Curr Protoc Cell Biol 22:Unit22.26, 2005.
7. Bayani J., Squire JA: Fluorescence in situ hybridization (FISH). Curr Protoc Cell Biol 22:Unit22.24, 2004.
8. Bonner RF, Emmert-Buck M., Cole K., Pohida T., Chuaqui R., Goldstein S., Liotta LA: Laser capture microdissection: molecular analysis of tissue. Science 278:1481, 1483, 1997.
9. Cairns P., Okami K., Halachmi S., Halachmi N., Esteller M., Herman JG, Jen J., Isaacs WB, Bova GS, Sidransky D.: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997-5000, 1997.
10. Cho EK, Tchinda J., Freeman JL, Chung YJ, Cai WW, Lee C.: Array-based comparative genomic hybridization and copy number variation in cancer research. Cytogenet Genome Res 115:262-272, 2006.
11. Cowell JK: One hundred years of retinoblastoma research: from the clinic to the gene and back again. Ophthalmic Paediatr Genet 10:75-88, 1989.
12. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z., Goldstein SR, Weiss RA, Liotta LA: Laser capture microdissection. Science 274:998-1001, 1996.
13. Espina V., Heiby M., Pierobon M., Liotta LA: Laser capture microdissection technology. Expert Rev Mol Diagn 7:647-657, 2007.
14. Esposito G.: Complementary techniques: laser capture microdissection-increasing specificity of gene expression profiling of cancer specimens. Adv Exp Med Biol 593:54-65, 2007.
15. Francke U., Kung F.: Sporadic bilateral retinoblastoma and 13q-chromosomal deletion. Med Pediatr Oncol 2:379-385, 1976.
16. Francois J., Matton MT, De Bie S., Tanaka Y., Vandenbulcke D.: Genesis and genetics of retinoblastoma. Ophthalmologica 170:405-425, 1975.
17. Freeman DJ, Li AG, Wei G., Li HH, Kertesz N., Lesche R., Whale AD, Martinez-Diaz H., Rozengurt N., Cardiff RD, Liu X., Wu H.: PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3:117-130, 2003.
18. Gillespie JW, Ahram M., Best CJ, Swalwell JI, Krizman DB, Petricoin EF, Liotta LA, Emmert-Buck MR: The role of tissue microdissection in cancer research. Cancer J 7:32-39, 2001.
19. Goodrich DW, Lee WH: The molecular genetics of retinoblastoma. Cancer Surv 9:529-554, 1990.
20. Hacia JG, Fan JB, Ryder O., Jin L., Edgemon K., Ghandour G., Mayer RA, Sun B., Hsie L., Robbins CM, Brody LC, Wang D., Lander ES, Lipshutz R., Fodor SP, Collins FS: Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet 22:164-167, 1999.
21. Hande MP, Azizova TV, Geard CR, Burak LE, Mitchell CR, Khokhryakov VF, Vasilenko EK, Brenner DJ: Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome. Am J Hum Genet 72:1162-1170, 2003.
22. Harris H., Miller OJ, Klein G., Worst P., Tachibana T.: Suppression of malignancy by cell fusion. Nature 223:363-368, 1969.
23. Harris H., Sidebottom E., Grace DM, Bramwell ME: The expression of genetic information: a study with hybrid animal cells. J Cell Sci 4:499-525, 1969.
24. Jarcho J.: Restriction fragment length polymorphism analysis. Curr Protoc Hum Genet 2:Unit2.7, 2001.
25. John HA, Birnstiel ML, Jones KW: RNA-DNA hybrids at the cytological level. Nature 223:582-587, 1969.
26. Kadkol SS, Gage WR, Pasternack GR: In situ hybridization: theory and practice. Mol Diagn 4:169-183, 1999.
27. Kallioniemi OP, Kallioniemi A., Sudar D., Rutovitz D., Gray JW, Waldman F., Pinkel D.: Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol 4:41-46, 1993.
28. Kirby J., Heath PR, Shaw PJ, Hamdy FC: Gene expression assays. Adv Clin Chem 44:247-292, 2007.
29. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820-823, 1971.
30. Kuliev A., Verlinsky Y.: Meiotic and mitotic nondisjunction: lessons from preimplantation genetic diagnosis. Hum Reprod Update 10:401-407, 2004.
31. Lawyer FC, Stoffel S., Saiki RK, Myambo K., Drummond R., Gelfand DH: Isolation, characterization, and expression in Escherichia coli of the DNA polymerase gene from Thermus aquaticus. J Biol Chem 264:6427-6437, 1989.
32. Lee EY, Lee WH: Molecular cloning of the human esterase D gene, a genetic marker of retinoblastoma. Proc Natl Acad Sci U S A 83:6337-6341, 1986.
33. Lee WH, Bookstein R., Hong F., Young LJ, Shew JY, Lee EY: Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235:1394-1399, 1987.
34. Ma L., Teruya-Feldstein J., Behrendt N., Chen Z., Noda T., Hino O., Cordon-Cardo C., Pandolfi PP: Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev 19:1779-1786, 2005.
35. Michels E., De Preter K., Van Roy N., Speleman F.: Detection of DNA copy number alterations in cancer by array comparative genomic hybridization. Genet Med 9:574-584, 2007.
36. Mullis KB, Faloona FA: Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155:335-350, 1987.
37. Nickoloff JA, Sweetser DB, Clikeman JA, Khalsa GJ, Wheeler SL: Multiple heterologies increase mitotic double-strand break-induced allelic gene conversion tract lengths in yeast. Genetics 153:665-679, 1999.
38. Nicolaidis P., Petersen MB: Origin and mechanisms of nondisjunction in human autosomal trisomies. Hum Reprod 13:313-319, 1998.
39. Pinzani P., Orlando C., Pazzagli M.: Laser-assisted microdissection for real-time PCR sample preparation. Mol Aspects Med 27: 140-159, 2006.
40. Qian J., Jenkins RB, Bostwick DG: Determination of gene and chromosome dosage in prostatic intraepithelial neoplasia and carcinoma. Anal Quant Cytol Histol 20:373-380, 1998.
41. Radman M., Kinsella AR: Chromosomal events in carcinogenic initiation and promotion: implications for carcinogenicity testing and cancer prevention strategies. IARC Sci Publ 27:75-90, 1980.
42. Reuveni E., Ramensky VE, Gross C.: Mouse SNP Miner: an annotated database of mouse functional single nucleotide polymorphisms. BMC Genomics 8:24, 2007.
43. Saiki RK, Gelfand DH, Stoffel S., Scharf SJ, Higuchi R., Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491, 1988.
44. Saiki RK, Scharf S., Faloona F., Mullis KB, Horn GT, Erlich HA, Arnheim N.: Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354, 1985.
45. Scharf SJ, Horn GT, Erlich HA: Direct cloning and sequence analysis of enzymatically amplified genomic sequences. Science 233:1076-1078, 1986.
46. Shriver MD, Jin L., Boerwinkle E., Deka R., Ferrell RE, Chakraborty R.: A novel measure of genetic distance for highly polymorphic tandem repeat loci. Mol Biol Evol 12:914-920, 1995.
47. Sorlie T., Perou CM, Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen MB, van de Rijn M., Jeffrey SS, Thorsen T., Quist H., Matese JC, Brown PO, Botstein D., Eystein Lonning P., Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869-10874, 2001.
48. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H., Ligon AH, Langford LA, Baumgard ML, Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng DH, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362, 1997.
49. Strong LC, Knudson AG Jr: Letter: second cancers in retinoblastoma. Lancet 2:1086, 1973.
50. Teng DH, Hu R., Lin H., Davis T., Iliev D., Frye C., Swedlund B., Hansen KL, Vinson VL, Gumpper KL, Ellis L., El-Naggar A., Frazier M., Jasser S., Langford LA, Lee J., Mills GB, Pershouse MA, Pollack RE, Tornos C., Troncoso P., Yung WK, Fujii G., Berson A., Steck PA: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221-5225, 1997.
51. Thiagalingam S., Laken S., Willson JK, Markowitz SD, Kinzler KW, Vogelstein B., Lengauer C.: Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A 98:2698-2702, 2001.
52. Thompson CT, Gray JW: Cytogenetic profiling using fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH). J Cell Biochem Suppl 17G:139-143, 1993.
53. Vogelstein B., Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y., White R.: Allelotype of colorectal carcinomas. Science 244:207-211, 1989.
54. Wang SI, Parsons R., Ittmann M.: Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin Cancer Res 4:811-815, 1998.
55. Wilson MG, Ebbin AJ, Towner JW, Spencer WH: Chromosomal anomalies in patients with retinoblastoma. Clin Genet 12:1-8, 1977.
56. Wongsurawat VJ, Finley JC, Galipeau PC, Sanchez CA, Maley CC, Li X., Blount PL, Odze RD, Rabinovitch PS, Reid BJ: Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Cancer Epidemiol Biomarkers Prev 15:509-516, 2006.
57. Weinberg RA: The Biology of Cancer. Garland Science, New York, NY, 2007.